The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.
The first major contract in the President’s Precision Medicine Initiative, for $142 million over 5 years, will go to the Mayo Clinic in Rochester, Minnesota, announced Kathy Hudson, PhD, deputy director for science, outreach, and policy at the National Institutes of Health.
The Mayo Clinic will use the award to build what Dr Hudson described as the world’s largest research biobank, with a capacity for 33 million specimens, and make data and samples available for widely shared science.
“What we’re trying to do is build a cohort of a million or more volunteers,” she told attendees at the Big Data in Biomedicine 2016 Conference in Stanford, California.
Although it won’t be statistically representative, “we hope it will reflect the diversity and richness of our population,” she noted.
Participation in the Precision Medicine Initiative cohort will be open to everyone, and participants will be partners at every step, from the planning groups to the Institutional Review Board, said Nancy Kass, ScD, a bioethicist at Johns Hopkins University in Baltimore, Maryland, who will chair the board for the cohort.
Read full, original post: Mayo Clinic Gets $124 Million for Precision Medicine Biobank
